BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 26988311)

  • 1. The developmental expression of the CDK inhibitor p57(kip2) (Cdkn1c) in the early mouse placenta.
    Saunders AC; McGonnigal B; Uzun A; Padbury J
    Mol Reprod Dev; 2016 May; 83(5):405-12. PubMed ID: 26988311
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Periodic expression of the cyclin-dependent kinase inhibitor p57(Kip2) in trophoblast giant cells defines a G2-like gap phase of the endocycle.
    Hattori N; Davies TC; Anson-Cartwright L; Cross JC
    Mol Biol Cell; 2000 Mar; 11(3):1037-45. PubMed ID: 10712518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The dual roles of geminin during trophoblast proliferation and differentiation.
    de Renty C; Kaneko KJ; DePamphilis ML
    Dev Biol; 2014 Mar; 387(1):49-63. PubMed ID: 24412371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Csf2 null mutation alters placental gene expression and trophoblast glycogen cell and giant cell abundance in mice.
    Sferruzzi-Perri AN; Macpherson AM; Roberts CT; Robertson SA
    Biol Reprod; 2009 Jul; 81(1):207-21. PubMed ID: 19228596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p57(Kip2) regulates the proper development of labyrinthine and spongiotrophoblasts.
    Takahashi K; Kobayashi T; Kanayama N
    Mol Hum Reprod; 2000 Nov; 6(11):1019-25. PubMed ID: 11044465
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of trophoblast stem cells into giant cells is triggered by p57/Kip2 inhibition of CDK1 activity.
    Ullah Z; Kohn MJ; Yagi R; Vassilev LT; DePamphilis ML
    Genes Dev; 2008 Nov; 22(21):3024-36. PubMed ID: 18981479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The cyclin-dependent kinase inhibitor p57Kip2 regulates cell cycle exit, differentiation, and migration of embryonic cerebral cortical precursors.
    Tury A; Mairet-Coello G; DiCicco-Bloom E
    Cereb Cortex; 2011 Aug; 21(8):1840-56. PubMed ID: 21245411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of p57
    Takahashi K; Yoneyama Y; Koizumi N; Utoguchi N; Kanayama N; Higashi N
    Placenta; 2021 Jan; 104():168-178. PubMed ID: 33360007
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide expression profiling of placentas in the p57Kip2 model of pre-eclampsia.
    Knox KS; Baker JC
    Mol Hum Reprod; 2007 Apr; 13(4):251-63. PubMed ID: 17289831
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional Versatility of the CDK Inhibitor p57
    Creff J; Besson A
    Front Cell Dev Biol; 2020; 8():584590. PubMed ID: 33117811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic and Epigenetic Control of CDKN1C Expression: Importance in Cell Commitment and Differentiation, Tissue Homeostasis and Human Diseases.
    Stampone E; Caldarelli I; Zullo A; Bencivenga D; Mancini FP; Della Ragione F; Borriello A
    Int J Mol Sci; 2018 Apr; 19(4):. PubMed ID: 29614816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased expression of vascular endothelial growth factor in placentas of p57(Kip2) null embryos.
    Matsuura T; Takahashi K; Nakayama K; Kobayashi T; Choi-Miura NH; Tomita M; Kanayama N
    FEBS Lett; 2002 Dec; 532(3):283-8. PubMed ID: 12482580
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Beckwith-Wiedemann-Associated
    Stampone E; Bencivenga D; Barone C; Di Finizio M; Della Ragione F; Borriello A
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299047
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p57(Kip2) and cancer: time for a critical appraisal.
    Borriello A; Caldarelli I; Bencivenga D; Criscuolo M; Cucciolla V; Tramontano A; Oliva A; Perrotta S; Della Ragione F
    Mol Cancer Res; 2011 Oct; 9(10):1269-84. PubMed ID: 21816904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The product of the imprinted gene IPL marks human villous cytotrophoblast and is lost in complete hydatidiform mole.
    Saxena A; Frank D; Panichkul P; Van den Veyver IB; Tycko B; Thaker H
    Placenta; 2003; 24(8-9):835-42. PubMed ID: 13129680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hallmarks of CDKN1C (p57, KIP2) in cancer.
    Kavanagh E; Joseph B
    Biochim Biophys Acta; 2011 Aug; 1816(1):50-6. PubMed ID: 21447370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p57(Kip2) knock-in mouse reveals CDK-independent contribution in the development of Beckwith-Wiedemann syndrome.
    Duquesnes N; Callot C; Jeannot P; Daburon V; Nakayama KI; Manenti S; Davy A; Besson A
    J Pathol; 2016 Jul; 239(3):250-61. PubMed ID: 27015986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different expression patterns of p27 and p57 proteins in benign and malignant melanocytic neoplasms and in cultured human melanocytes.
    Curry JL; Richards HW; Huttenbach YT; Medrano EE; Reed JA
    J Cutan Pathol; 2009 Feb; 36(2):197-205. PubMed ID: 18647205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development.
    Yan Y; Frisén J; Lee MH; Massagué J; Barbacid M
    Genes Dev; 1997 Apr; 11(8):973-83. PubMed ID: 9136926
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Down-regulation of p57Kip2 induces prostate cancer in the mouse.
    Jin RJ; Lho Y; Wang Y; Ao M; Revelo MP; Hayward SW; Wills ML; Logan SK; Zhang P; Matusik RJ
    Cancer Res; 2008 May; 68(10):3601-8. PubMed ID: 18483241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.